Back to Search Start Over

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database

Authors :
Frank S. Lieberman
Deborah T. Blumenthal
Luis Souhami
Minesh P. Mehta
Dennis C. Shrieve
Benjamin W. Corn
Kirsten Hopkins
Egils Valeinis
Felix Bokstein
David G Brachman
Peixin Zhang
Maria Werner-Wasik
Minhee Won
Grant K. Hunter
Merideth M Wendland
Mark R. Gilbert
Steven P. Howard
Cliff G. Robinson
Paul D. Brown
Source :
Neuro-Oncology. 20:966-974
Publication Year :
2018
Publisher :
Oxford University Press (OUP), 2018.

Abstract

Background We previously reported the unexpected finding of significantly improved survival for newly diagnosed glioblastoma in patients when radiation therapy (RT) was initiated later (>4 wk post-op) compared with earlier (≤2 wk post-op). In that analysis, data were analyzed from 2855 patients from 16 NRG Oncology/Radiotherapy Oncology Group (RTOG) trials conducted prior to the era of concurrent temozolomide (TMZ) with RT. We now report on 1395 newly diagnosed glioblastomas from 2 studies, treated with RT and concurrent TMZ followed by adjuvant TMZ. Our hypothesis was that concurrent TMZ has a synergistic/radiosensitizing mechanism, making RT timing less significant. Methods Data from patients treated with TMZ-based chemoradiation from NRG Oncology/RTOG 0525 and 0825 were analyzed. An analysis comparable to our prior study was performed to determine whether there was still an impact on survival by delaying RT. Overall survival (OS) was investigated using the Kaplan-Meier method and Cox proportional hazards model. Early progression (during time of diagnosis to 30 days after RT completion) was analyzed using the chi-square test. Results Given the small number of patients who started RT early following surgery, comparisons were made between >4 and ≤4 weeks delay of radiation from time of operation. There was no statistically significant difference in OS (hazard ratio = 0.93; P = 0.29; 95% CI: 0.80-1.07) after adjusting for known prognostic factors (recursive partitioning analysis and O6-methylguanine-DNA methyltransferase methylation status). Similarly, the rate of early progression did not differ significantly (P = 0.63). Conclusions We did not observe a significant prognostic influence of delaying radiation when given concurrently with TMZ for newly diagnosed glioblastoma. The effects of early (1-3 wk post-op) or late (>5 wk) initiation of radiation tested in our prior study could not be replicated.

Details

ISSN :
15235866 and 15228517
Volume :
20
Database :
OpenAIRE
Journal :
Neuro-Oncology
Accession number :
edsair.doi...........dbc56e16929b19b8a782361b9bfcee19
Full Text :
https://doi.org/10.1093/neuonc/noy017